Ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
- Catalog No. :
- ACBLJC761
- CAS No. :
- 113028-17-4
- Molecular Formula :
- C18H20FN3O3S
- Molecular Weight :
- 377.44
IUPAC Name:ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$63.00Login to see priceIn stockInquiry
10g95%$103.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | Ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate |
|---|---|
| IUPAC Name | ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate |
| MDL No. | MFCD08063938 |
| Molecular Formula | C18H20FN3O3S |
| Molecular Weight | 377.44 |
| SMILES | O=C(C1=C(SC2C)N2C3=C(C=C(F)C(N4CCNCC4)=C3)C1=O)OCC |
| InChI Key | XWZXETKTFKCCPB-UHFFFAOYSA-N |
| Synonym | 6-FLUORO-1-METHYL-4-OXO-7-(1-PIPERAZINYL)-4H-(1,3)THIAZETO(3,2-A)QUINOLINE-3-CARBOYLIC ACID ETHYL ESTER;6-FLUORO-1-METHYL-4-OXO-7-(1-PIPRAZINYL)-1H,4H-(1,3)THIAZETO(3,2-A)QUINOLINE-3-CARBOXYLIC ACID, ETHYL ESTER;ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate;6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-1H,4H-[1,3]-thiazeto[3,2-a]-3-quinolinecarboxylic acid ethyl ester;Ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piprazinyl)-4H-(1,3)-thiazeto(3,2-a);ETHYL 6-FLUORO-1-METHYL-4-OXO-7-(1-PIPERAZINYL)-4H-(1,3)-THIAZETO(3,2-A) QUINOLINE-3-CARBOXYLATE;Prulifloxacin Intermediate PL-10;Ethyl 6-fluoro-1-Methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate |
| CAS No. | 113028-17-4 |
| PubChem CID | 10249018 |
Safety Data
- Pictogram
- Signal Word
- Achtung
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338

